Jeanine Albu, M.D.

ACADEMIC TRAINING

1974-1978Institute of Medicine and Pharmacy, Bucharest, Roumania
1978-1982Sackler Medical School, Tel Aviv University, Israel
1982M.D. degree from Sackler Medical School
1985-New York State License

TRAINEESHIP

1981-1982Rotating Subintern, Bronx- Lebanon Hosp., Bronx, N.Y.
1982-1985Resident in Internal Medicine, Bronx-Lebanon Hospital
1985-1987Fellow in Endocrinology, Metabolism and Nutrition
St. Luke's- Roosevelt Hospital, New York, N.Y.

BOARD MEMBERSHIP

1985Diplomate of the American Board of Internal Medicine
1987Diplomate of the American Board of Endocrinology and Metabolism

PROFESSIONAL ORGANIZATIONS AND SOCIETIES

1985-1989Associate of the American College of Physicians
1989-Member of the American College of Physicians
1987-Member of the American Diabetes Association Professional section
1987-Member of the New York Diabetes Association
1991-Member of the American Federation for Clinical Research
1995-Member of the Endocrine Society
1995-Member of the American Association for the Advancement of Science
1997-Member of the North American Association for the Study of Obesity
1998-2003Member, Financial Committee,
North American Association for the Study of Obesity
2001-Chair, Financial Committee,
North American Association for the Study of Obesity
2003Chair, Oral Abstracts Session,
American Diabetes Assocation Annual Meeting, New Orleans, June, 2003
2003-Member, Publication Committee,
North American Association for the Study of Obesity
2004Chair, Oral Abstracts Session,
The Endocrine Society Annual Annual Meeting, New Orleans, June, 2004
2004-Chair, Publication Committee,
North American Assocation for the Study of Obesity

ACADEMIC APPOINTMENTS

1987-1991Associate in Clinical Medicine,
College of Physicians & Surgeons,
Columbia University, New York, NY
1991-1995Assistant Professor of Clinical Medicine,
College of Physicians and Surgeons,
Columbia University, New York, NY
1995-2002Assistant Professor of Medicine,
College of Physicians and Surgeons,
Columbia University, New York, NY
2002-Associate Professor of Clinical Medicine,
College of Physicians and Surgeons,
Columbia University, New York, NY

HOSPITAL APPOINTMENTS

1987-1991Junior Assistant Attending Physician
St. Luke's-Roosevelt Hospital Center, New York, N.Y.
1991-1997Assistant Attending Physician
St. Luke's-Roosevelt Hospital Center, New York, N.Y.
1997-Associate Attending Physician
St. Luke's-Roosevelt Hospital Center, New York, N.Y.
1987-1991Attending-Ambulatory Care Program
Endocrinology and Diabetes Clinic, St. Luke's site
St. Luke's-Roosevelt Hospital Center
1991-Chief, Diabetes and Endocrinology Clinic
Ambulatory Care Program, St. Luke's site
St. Luke's Roosevelt Hospital Center
2000-Associate Director
Endocrinology Fellowship Training Program
Division of Endocrinology and Metabolism
St. Luke's Roosevelt Hospital Center

AWARDS and HONORS

1986 Merit H. Cash Award, New York State Medical Society, for best clinical paper submitted by a house staff member: "A case of Pentamidine-Induced Diabetes Mellitus"
1992 Research Career Development Award , American Diabetes Association
1993 Clinical Investigator Award, National Institutes of Health
1996- 1999 Listed in the Woodward /White's: The Best Doctors in America: Northeast Region
2000-2004 Co-Chair, Non-Pharmacologic Treatment Working Group, BARI 2D Clinical Trial (Bypass Revascularization Intervention Trial in Type 2 Diabetes)
2000- Associate Director, Columbia University GCRC (General Clinical Research Center)
2001-2003 Chair, Financial Committee, North American Association for the Study of Obesity
2004- Chair, Publication Committee, North American Association for the Study of Obesity
2004- Co-Director, Lifestyle Management Intervention Center BARI 2D Clinical Trial (Bypass Revascularization Intervention Trial in Type 2 Diabetes)
2004- Co-Director, Diabetes Education and Empowerement Program (DEEP), St. Luke's-Roosevelt Hospital Center
2005- Research Award, American Diabetes Association

RESEARCH GRANT SUPPORT

A. PAST

Grant SupportTitleP.I./Award
NIH
Obesity Research Center,
1988-1991
Feasibility Grant
DK26687		 The effect of repeated cycles of weight loss and gain on body composition and metabolic disturbances in morbid obesity J. Albu
NIH
1988-1992		 Thermogenesis and exercise in lean and obese men K. Segal
J. Albu, 20%
1992-1997    J. Albu, 15%
Genentech Grant
1990		 A phase I study of the safety and pharmacokinetics following repeat administration of rhIGF-I by the iv route, in healthy adult males J. Albu
Genentech Grant
1991-1992		 A phase I study of the safety and pharmacokinetics following repeat administration of the rhIGF-I by the subcutaneous route The effect of rhIGF-I on appetite J. Albu
NIH
RO1DK40414
1992-1996		 Obesity in Black Women F.X. Pi-Sunyer
J. Albu, 15%
American Diabetes Association
1992-1993
(Research Career Development Award)		 The differential metabolic effects of insulin resistance in obesity J. Albu
NIH
1993-1998
(Clinical Investigator Award)
K08DK02155		 The differential effects of insulin resistance in obesity J. Albu
Weight Watchers Foundation
1993-1995		 The differential effects of insulin resistance in obesity J. Albu
St. Luke's Roosevelt Institute for Health Sciences
1993		 Recipient of the "Small Instrumentation Grant " J. Albu
Genentech Grant
1994-1995		 A phase II randomized, double- blind, placebo-controlled, dose- ranging study of the safety and efficacy of rhIGF-I administered twice daily for the treatment of Type II Diabetes Mellitus. J. Albu
Genentech Grant
1995-1996		 A randomized, double-blind, placebo-controlled, multicenter, multidose study of the combined effects of subcutaneously administered insulin and rhIGF-1 in subjects with insulin dependent diabetes mellitus J. Albu
Genentech Grant
1996		 A phase II randomized, double-blind, placebo-controlled, multidose study of the safety and pharmacokinetic/ pharmacodynamic effects of rhIGF-1 in combination with insulin for the treatment of Type II Diabetes Mellitus J. Albu
Genentech Grant
1996-1997		 A phase II randomized, double-blind, placebo-controlled, dose-ranging study of the safety and efficacy of rhIGF-1 administered twice daily, in combination with sulfonylurea, for the treatment of Type II Diabetes Mellitus J. Albu
WRISC Grant
1998-1999		 Ethnic Energy Expenditure Mechanisms D. Gallagher
J. Albu, 10%
Novo Nordisk
1998-1999		 Insulin NPH and Regular Premix Ratio 50/50: A randomized, Double-blind, Single-dose Two-period Crossover Study, comparing Pharmacokinetic and Pharmacodynamic properties using the Euglycemic Clamp Technique J. Albu
WRISC Grant
1999-2000		 Genetic Admixture and Resting Energy Expenditure in African American Women D. Allison
J. Albu, 4%
Eli Lilly
1999-2000		 Comparison of an Incremental Weight-based Dose Regimen with An Individualized Dosage Adjusted According to the IGF-I Response in Adults With Growth Hormone Deficiency J. Albu
Eli Lilly
1999-2003		 HYPOOCS: GDGE J. Albu
Hoffman LaRoche
1998-1999		 Efficacy of orlistat plus diet in obese type II diabetic patients inadequately controlled with metformin monotherapy J. Albu
Pfizer
1999-2000		 Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin Therapy in Subjects With type 2 Diabetes Mellitus: a Six-month, Outpatient, Parallel, Comparative Trial J. Albu
Pfizer
1999-2000		 Efficacy and Safety of Inhaled Human Insulin Therapy in Subjects With type 2 Diabetes Mellitus not well Controlled with Combination Oral Agents: A Three-month Outpatient, Parallel, Comparative trial J. Albu
Pfizer
1999-2000		 Efficacy and Safety of Inhaled Compared with Subcutaneous Human Insulin Therapy in Subjects With type 1 Diabetes Mellitus: a Six-month, Outpatient, Parallel, Comparative Trial J. Albu
NIH
1998-2003
RO1 DK53089		 Human Food Intake Control: Gastric and Intestinal Factors H. Kissileff
J. Albu, 6%
Novartis Pharmaceuticals
2002-20004		 Gene expression profile of adipose tissue and skeletal muscle of lean vs obese insulin resistant women before during and after weight loss J. Albu
NY State Grant
2004
Diabetes Research Bridge Grants		 Obesity in Black Women J Albu
NIH
1997-2004
RO1DK40414		 Obesity in Black Women F.X.Pi-Sunyer
J. Albu, 5%


B. ACTIVE

a. Pharmaceutical

Grant SupportTitleP.I./Award
Eli Lilly
2003-		 The Hypopituitary Control and Complications Study (HYPOOCS:GDGA) J. Albu
Amylin Pharmaceuticals
2003-		 Pramlitide and Exenatide Studies For Type 1 and Type 2 Diabetes J. Albu


b. NIH/Investigator-initiated

Grant SupportTitleP.I./Award
NIH
1995-2005
P30DK26687		 New York Obesity Research Center F.X.Pi-Sunyer, PI
J. Albu, 5%
NIH
2001-2007
NHLBI contract		 Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes (BARI 2D) Lifestyle Intervention Management Center J. Albu
Diabetes PI
Co-Director
NIH
2000-2005
RO1HL65938-01		 Lipoprotein and Adipose Tissue Metabolism in HIV J. Albu, PI
subcontract 15%
NIH
2000-2008
MO1RR00645		 Columbia GCRC: Supplemental Application for Clinical Research at St. Luke's Roosevelt Hospital Colten, PI
J. Albu, 10%
Associate Director
NIH
2001-2005
PO1DK42618-11		 Body Composition: Methods, Models & Clinical Applications Heymsfield, PI
J. Albu, 15%
NIH
2001-2006
RO1DK60412		 Fat cellsize, Muscle Lipid Infiltration and Insulin Resistance J. Albu, PI
subcontract 15%
NIH
2003-2007
P30 DK63608		 Diabetes and Endocrinology Research Center (DERC) D. Accili, PI
J. Albu, 8%
NIH
2004-2008
RO1 DK065515		 Growth Hormone and Rosiglitazone for Visceral Adiposity in HIV Glessby, PI
J. Albu, 10%
American Diabetes Association
2004-2007		 Intra-myocellular Lipid: Effcet of Race and Diet J. Albu
New York State Grant
2003-2008
Contract		 Diabetes Education and Empowerment Program J. Albu


DEPARTMENTAL and UNIVERSITY COMMITTEES

1987-1989 Member, Education Committee of the Medical Board St. Luke's Roosevelt-Hospital Center
1987-1988 Physician Advisor, Quality Assurance Program
1988- Member, Endocrinology Fellows Board Evaluation Committee, Division of Endocrinology and Metabolism St. Luke's site, St. Luke's-Roosevelt Hospital Center
1989- Member, Nutrition Committee of the Medical Board
1990- Member, Medical Board of the St. Luke's-Roosevelt Hospital Center
1988-1994 Medical Coordinator, Obesity Surgery Program St. Luke's-Roosevelt Hospital Center
1989-1993 Length of Stay Committee, Dept. of Medicine St. Luke's site, St. Luke's Roosevelt-Hospital Center
1991-1994 Bedside Glucose Monitoring Committee Dept. of Medicine St. Luke's Roosevelt-Hospital Center
1992- Podiatry Program Evaluation, Dept. of Medicine St. Luke's Roosevelt-Hospital Center
2003- Radiation Safety Committee, Dept. of Nuclear Medicine Medical Board, St. Luke's Roosevelt Hospital Center


TEACHING EXPERIENCE and RESPONSIBILITIES

1988-2000 Preceptor, Physical Diagnosis Course, Columbia University College of Physicians and Surgeons
1992-2001 Preceptor, Clinical Clerkship in Medicine
Columbia University
College of Physicians and Surgeons
1987-
(2-3 months/year) 		Medical Service Attending on Service
St. Luke's/Roosevelt Hospital Center
1987-
(2-3 months/year) 		Endocrinology, Metabolism and Nutrition Attending on Service at St. Luke's/Roosevelt Hospital Center
1988-2000 Supervisor, Endocrinology and Nutrition
Fellowship Program, St. Luke's site
St. Luke's /Roosevelt Hospital Center
1997- Member, Supervisory Committee,
Endocrinology and Nutrition Fellowship Program,
St. Luke's site, St. Luke's /Roosevelt Hospital Center
2000- Associate Program Director
Endocrinology/Metabolism Fellowship Program
St. Luke's-Roosevelt Hospital Center
Predoctoral Mentorship
1990
Jane Lee
1994
Leora Hamberger
Christiana Konorides
1995
Yuan-Pei Chen
2001
Jason Wagner 		Preceptor, Master Thesis Program
Institute of Human Nutrition
Columbia University, New York
1993
Megan Chen
Pamela Greenhouse 		Preceptor, Master Thesis Program
Nutrition program
New York University, NYC
1995-1998
Julia Johnson
1998
James Gasperino
2000
Furcy Paultre
2002-
Evan Berk 		Doctorate Thesis Examination Committee Member
Institute of Human Nutrition, Columbia University, NY
2000-2002
Albert Kovera 		Doctorate Thesis Advisor
Teachers College EdD Program
Columbia University
2005-
Marsha Wainwright 		Mentor, NIH/NIDDK, Minority Supplement Award
Medical Student, Rutgers Medical School
2005-
Lucien Iancovici 		Mentor, Summer Research Fellowship Award
Medical Student, Tufts Medical School
Postdoctoral Mentorship
1998-1999
Jason Chou PhD
1999-2001
Tarek Redda MD
2001-2002
Julia Johnson PhD
2002-2003
Gabriel Ionescu MD 		Post-Doctoral Research Fellows Supervision, Obesity Research Center
2001-2002
Nazia Raja-Khan MD
2003
Andrew Chou MD
2004-2005
Negah Rassouli MD 		Post-Doctoral St. Luke's Roosevelt Hospital Medical Residents Research Project Supervisor
2002-
Julia Johnson PhD 		Overall Mentor, NIH/NIDDK K08 Award Program

OTHER PROFESSIONAL ACTIVITIES

A. Invited Lectures (selected)

  1. Obesity Management Conference, Naples, Florida, February 1997.
  2. "Overview of Obesity in African Americans and Other Minorities: What are the Accurate Indices" presented as guest faculty at the Ohio State University , Columbus, Ohio, 1998
  3. "Body Composition Evaluation in Growth-Hormone Deficient Adults", Third International HypoCCS Symposium, Venice, Italy, 1999.
  4. "Obesity: When It Should Be Considered a Disease? When and How It Should Be Treated?" Medical Crossfire Teleconference Debate, New York, NY 1999
  5. Contributor to the development of "Obesity Management Information Kit", College of Physicians and Surgeons of Columbia University and MPE Communications, 1999
  6. C.O.R.E. (Centers for Obesity Research and Education) New York site lectures: 3-4/year, 1999-
  7. "Obesity: Management Strategies in Primary Care", 94th Annual Scientific Assembly, Southern Medical Association, Orlando, FL, 2000
  8. Presentations of the "Non-Pharmacologic Treatment" for the BARI2D Clinical Trial (Bypass/angioplasty/revascularization intervention in type 2 diabetes), Pittsburgh, PA, 2000-2001
  9. "Diabetes and Obesity: the Role of Body Composition" presented as guest faculty at the Fifth Biannual Diabetes Update, Columbus, Ohio, May 2001
  10. " Diabetes and Obesity in Minorities: The Role of Body Composition" presented as guest faculty at the National Medical Association Annual Meeting, Internal Medicine Section, Endocrinology, Nashville, TN, August 2001
  11. "Regulation of body fat distribution with respect to visceral fat biology" presented at the 2001 FASEB Summer Research Conference on "Advances in Obesity-From Environment to the Gene", Snowmass Village, CO, August 2001
  12. "Adipose Tissue Metabolism in Visceral Obesity", Pennington Center for Obesity Research Lecture Series, Pennington Center, Baton Rouge Louisiana, May 9th, 2002
  13. "Medical Management of Obesity" for the "Spring 2002 Update in Internal Medicine", Saint Vincent Catholic Medical Centers, Staten Island, New York, May 24th, 2002
  14. "Obesity and the Metabolic Syndrome: the Urgency and Understanding of Clinical Consequences" for Liberty Communications Network/Medical Crossfire, Univ. of Pennsylvania, Philadelphia PA, June 29th, 2002
  15. "Obesity, Insulin Resistance and Atherosclerotic Disease" and "Management of Insulin Resistance in HIV" for the Course - Symposium "Atherosclerotic Disease and HIV Infection", St. Luke's Roosevelt Hospital Center, Division of Gastroenterology, New York, NY, Oct. 2002
  16. "Insulin Resistance and Type 2 Diabetes Mellitus in African-Americans", Grand Rounds, North General Hospital, New York, NY, Dec. 2003
  17. "Metabolic syndrome/Insulin Resistance: Relationship to Atherosclerotic Disease" for The New York Course-Symposium : HIV Lipodystgrophy Management, New York City, May 2004
  18. "Metbolic Syndrome: What is it and Why is it Important" Science and Art of Medicine Symposium, St. Luke's Roosevelt Hospital Center Medical Board, April 13th 2005
B. Editorial C. Consultative

Reviewer for the following peer-reviewed Journals: D. Media

E. Community Service

PUBLICATIONS

A. Original, peer-reviewed articles
  1. Segal P, Albu J, Almog S, Berezin M: Prevalence of chlorpropamide alcohol flush in Jewish Israeli diabetics. Israeli J. of Medical Sciences 21:98-101, 1985
  2. Segal KR, Albu J, Gutin B, Pi-Sunyer FX: Thermic effect of food and exercise in lean and obese men of similar lean body mass. Am. J. Physiol. 252:E110-E117, 1987
  3. Segal KR, Dunaif A, Gutin B, Albu J, Nyman A, Pi-Sunyer FX: Body composition, not body weight, is related to cardiovascular risk factors and sex hormone levels in men. J. Clin. Invest. 80:1050-1055, 1987
  4. Segal KR, Adonio A, Abalos A, Albu J, Blando L, Tomas MB, Pi- Sunyer FX: The effect of exercise training on insulin sensitivity and glucose metabolism in lean , obese and diabetic men. J Appl Physiol.71(6):2402-2411, 1991
  5. Lieberman SA, Bukar J, Chen SA, Ceniker AC, Compton PG, Cook J, Albu J, Perlman AJ, Hoffman AR. Effects of recombinant human insulin-like growth factor (rhIGF-I) on total and free IGF-I concentrations, IGF binding proteins and glycemic response in humans. J. Clin. Endocrinol. Metab. 75:30-36, 1992
  6. Albu J, Smolowitz J, Lichtman S, Heymsfield S, Wang J, Pierson RN, Pi-Sunyer FX. Composition of weight loss in severely obese women: a new look at old methods. Metabolism. 41:1068-1074,1992.
  7. Segal KR, Albu J, Chun A, Edano E, Legaspi B, Pi-Sunyer FX. Independent effects of obesity and insulin resistance on postprandial thermogenesis in men. J. Clin. Invest. 89:824-833, 1992
  8. *Albu J, Murphy L, Fraeger D, Johnson JA, Pi-Sunyer FX. Visceral fat and race-dependent health risks in obese, nondiabetic, premenopausal women. Diabetes, 46:456-462, 1997.
  9. *Albu J, Shur M, Murphy L, Curi M, Heymsfield S, Pi-Sunyer FX. Resting metabolic rate in obese, premenopausal black women.. Am J Clin Nutr, 66:531-538, 1997
  10. Allison DB, Nathan JS, Albu J, Heymsfield SB, Duprat LJ, Pi-Sunyer FX. Measurement challenges and other practical concerns when studying massively obese individuals. Int J of Eating Disorders. 24:275-284, 1998.
  11. *Marcus MA, Murphy L, Pi-Sunyer FX, Albu J. Insulin sensitivity and serum triglyceride level in white and black obese women: relationship to visceral and truncal subcutaneous fat. Metabolism, 48:194-199, 1999
  12. *Albu J, Curi M, Shur M, Murphy L, Matthews DE, Pi-Sunyer FX. Systemic resistance to the anti-lipolytic effect of insulin in black and white women with visceral obesity. Am J Physiology, 277 (Endocrinol. Metab. 40): E551-E560, 1999
  13. Gu W, Tu Z, Kleyn P, Kissebah A, Duprat L, Lee J, Chin W, Maruti S, Deng N, Fisher S, Franco LS, Burn P, Yagaloff KA, Nathan J, Heymsfield SB, Albu J, Pi-Sunyer FX, Allison DB. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes, 48:635-639, 1999.
  14. *Albu J, Kovera AJ, Johnson JA. Fat distribution and health in obesity: In vivo Body Composition Studies, Annals of the New York Academy of Sciences 904:491-501, 2000
  15. Gallagher D, Kovera AJ, Clay-Williams G, Agin D, Leone J, Albu J, Matthews DE, Heymsfield SB. Weight loss in post-menopausal women: no evidence of adverse alterations in body composition. Am J Physiol, Endocrinol Metab, 279: E124-E131, 2000
  16. *Johnson JA, Fried SK, Pi-Sunyer FX, Albu J. Impaired insulin action in subcutaneous adipocytes from women with visceral obesity. Am J Physiol Endocrinol Metab 280:E40-E49, 2001
  17. Engelson ES, Glesby M, Sheikhan J, Albu J, Wang J, Heymsfield SB, Kotler DP. Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection: interim analysis. JAIDS 30: 379-391, 2002
  18. Fontaine KR, Gadbury G, Heymsfield SB, Kral J, Albu JB, Allison D. Quantitative prediction of body diameter in severely obese individuals. Ergonomics, 45(1):49-60, 2002
  19. Zheng K, Sun W, Werner P, Kovera A, Albu J, Pi-Sunyer FX, Boozer C. Sleeping metabolic rate in relation to body mass index and body composition. Int J Obesity, 26:376-383, 2002
  20. Nielsen S, Gou Z, Albu J, Klein S, Jensen MD. Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest, 111:7, 981-988, 2003
  21. He Q, Engelson E, Albu J, Heymsfield S, Kotler DP. Preferential loss of omental-mesenteric fat during growth hormone therapy in HIV-associated lipodystrophy. J Appl Physiol, 94:5, 2051-7, May 2003.
  22. He Q, Heo M, Heshka S, Wang J, Pierson Jr RN, Albu J, Wang Z, Heymsfield S, Gallagher D. Total body potassium differs by sex and race across the adult age span. Am J Clin Nutr, 78:1, 72-77, July 2003
  23. Fernandez JR, Shriver MD, Beasley M, Rafla-Demetrious N, Parra E, Albu J, Nicklas B, Ryan AS, McKeigue PM, Weinsier RL, Allison DB. Association of African genetic admixture with resting metabolic rate and obesity among women. Obesity Research, 11:7, 904-911, 2003
  24. * Johnson J, Albu J, Engelson E, Fried S, Inada Y, Ionescu G, Kotler D. Increased systemic and adipose tissue cytokines in patients with HIV-associated lipodystrophy. Am J Physio - E&M. 286(2):E261-71, 2004
  25. Heilbronn LK, Janderora L, Rood J, Albu J, Kelley DE, Ravussin E, Smith SR. Relationship between serum resistance and insulin resistance in non-obese and obese diabetic subjects. In press, J Clin Endo Metab, 89(4):1844-8, 2004
  26. Shen W, Punyanitya M, Wang ZM, Gallagher D, St-Onge M-P, Albu J, Heymsfield SB, Heshka S. Visceral adipose tissue: Relationships between single slice areas and total volume. Am J Clin Nutr, 80:271-278, 2004.
  27. Kim J, Heshka S, Gallagher D, Kotler DP, Mayer L, Albu J, Shen W, Freda PU, Heymsfield SB. Intermuscular adipose tissue-free skeletal muscle mass: Estimation by dual-energy X-ray absorptiometry in adults. J Appl Physiol 97:655-60, 2004.
  28. Shen W, Punyanitya M, Wang Z, Gallagher D, St-Onge MP, Albu J, Heymsfield SB, Heshka S. Total body skeletal muscle and adipose tissue volumes: Estimation from a single abdominal cross-sectional image. J Appl Physiol, 97: 2333-2338, 2004.
  29. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB, Augustus AS. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obesity 29:281-286, 2005.
  30. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield S, Goodpaster B, Visser M, Harris TB. Adipose tissue in muscle: a novel depot similar in size to visceral adipose tissue. Am J Clin Nutr. 81:903-910, 2005
  31. Thomas-Geevarghese A, Raghavan S, Minolfo R, Holleran S, Ramakrishnan R, Ormsby O, Karmally W, Ginsberg HN, El-Sadr WM, Albu J and Berglund L. Postprandial response to a physiological caloric load in HIV-positive patients receiving a protease inhibitor-based or non nucleosidase reverse transcriptase inhibitor - based antiretroviral therapy. Am J Clin Nutr, In press, 2005.
  32. Falutz J, Allas S, Kotler D, Lussier B, Thompson M, Koutkia P, Albu JB, Trottier B, Routy JP, Cote P, Vachon L, Abribat T, Grinspoon S. A Placebo-Controlled, Dose-Ranging Study of a Growth Hormone Releasing Factor in HIV-infected Patients With Abdominal Fat Accumulation, AIDS, In press, 2005
  33. Albu JB, Kovera AJ, Allen L, Wainwright M, Berk B, Raja-Khan N, Janumala I, Burkey B, Heshka S, Gallagher D. Independent association of insulin resistance with increased inter-muscular adipose tissue and larger acute insulin response to glucose in African American vs. Caucasian non-diabetic women , Am J Clin Nutr, In revision, 2005.
  34. Berk ES, Kovera AJ, Boozer CN, Pi-Sunyer FX, Johnson JA, Albu JB. Adiponectin Levels during Low and High Fat Eucaloric Diets in Lean and Obese Women, Obesity Research, In revision, 2005
B. Editorials/Review Articles/Chapters
  1. Albu J: Nutritional management following massive upper gastrointestinal resection. Nutrition in Clinical Practice. 5:199-202, 1987
  2. Ferraro RT, Albu J: Nutrition support of the critically ill obese patient. Nutrition in Clinical Practice 4:125-126, 1989
  3. Albu J, Pi-Sunyer FX: Commentary for "Culture, Ethnicity, and Diabetes". Diabetes Spectrum 6:113-114, 1993
  4. Albu J, Konorides C, Pi-Sunyer FX. Weight control in diabetes mellitus: metabolic and cardiovascular effects. Diabetes Reviews. 3: 335-347, 1995
  5. Albu J, Reed G. Weight cycling: more questions than answers. Endocrine Practice, 1: 346-352, 1995.
  6. Albu J, Pi-Sunyer FX.: Obesity and Diabetes. Chapter in "Obesity Management" Bray and Bouchard, eds, 1997
  7. Albu J, Allison D, Boozer C, Heymsfield S, Kissileff H, Kretser A, Krumhar K, Leibel R, Nonas C, Pi-Sunyer FX, Van-Itallie T, Wedral E. Obesity Solutions: Report of a meeting . Nutrition Reviews, 55:150-156, 1997
  8. Albu J. Reply to HH Sandstead. Letter to the Editor. Am J Clin Nutr, 67: 741, 1998
  9. Albu J, Himmelfarb L. Chapter #8: Endocrine Diseases. Case 2: Type 2 Diabetes Mellitus. In Morrison G and Hark L (eds). Medical Nutrition and Diseases. 2nd ed. Blackwell Science, Malden, MA, 1999
  10. *Albu J, Raja-Khan N. The Management of the Obese Diabetic Patient. Prim Care Clin Office Pract, 30:465-491, 2003
  11. *Albu J, Raja-Khan N. Chapter #16: "The Management of the Obese Diabetic Patient". In Bray GA, ed, Office Management of Obesity, Elsevier Inc, Saunders, USA, 2004
  12. Albu J, Pi-Sunyer FX.: Obesity and Diabetes. Chapter in "Handbook of Obesity" Bray and Bouchard, eds, 2004, in press
C. Abstracts
  1. Segal KR, Dunaif A, Albu J, Gutin B, Pi-Sunyer FX: Cardiovascular risk factors in normal, overly fat, and overly muscular men. Circulation 74:II-383, 1985
  2. Segal KR, Gutin B, Albu J, Nyman A, Pi-Sunyer FX: Body fat and aerobic fitness in relation to resting metabolic rate and postprandial thermogenesis in man. Medicine and Science in Sports and Exercise 18:S102, 1986
  3. Segal KR, Albu J, Gutin B, Pi-Sunyer FX: Effect of sequence of meal and exercise on post-exercise thermic effect of food in lean and obese men. Clinical Research 34:393A, 1986
  4. Albu J, Heshka S, Heymsfield S: Correlates of self-reported large weight cycles in obese women. Int. J. Obesity, 13:390(A), June 1989
  5. Albu J, Lichtman S, Heymsfield S, Wang J, Pierson RN Jr, Pi-Sunyer FX: Reassessment of body composition models in morbidly obese. The FASEB J,3:A336, 1989.
  6. Segal KR, Abalos A, Albu J, Edano A, Ginsberg-Fellner F, Pi-Sunyer FX: Effect of exercise training on insulin sensitivity and the thermic effect of glucose in lean, obese and diabetic men. Clin. Research, 37:334A, 1989
  7. Segal KR, Pi-Sunyer FX, Albu J: Effect of exercise training on plasma lipids in lean, obese and type II diabetic men. Circulation 80: II-58, 1989
  8. Albu J, Smolowitz J, Lichtman S, Wang J, Pierson RN, Heymsfield S, Pi-Sunyer FX: Composition of weight loss during dieting in morbidly obese women. Clin. Research 38(2):744A, 1990
  9. Lieberman SA, Chen SA, Albu J, Legaspi B, Maneval DC, Celniker AC, Compton P, Bukar J, Hoffman AR, Perlman AJ. Effects of multiple injections of rhIGF-I on free IGF-I disposition and glycemic response in humans. Presented at the 2nd International IGF Symposium, San Francisco, Jan. 1991
  10. Albu J, Smolowitz J, Lichtman S, Heymsfield S, Pi-Sunyer FX. Weight gain after weight loss: body composition and metabolic changes. Am J Clin Nutr 53:P-13(A), 1991
  11. Segal KR, Albu J, Chun A, Legaspi B, Pi-Sunyer FX: Thermic effect of food in lean and obese men with low and high levels of insulin sensitivity. Clin Res., 39(2):204(A), 1991.
  12. Albu J, Heymsfield S, Pierson RN Jr., Pi-Sunyer FX, Thornton J, Wang J. Body fat distribution alters the relationship between percent fat and BMI in women, after adjusting for age and race. Obesity Research,1(suppl.1): 34S 1992
  13. Albu J, LaChaussee J, Bukar J, Gesundheit N, Kissileff H. Failure of acute administration of rhIGF-I to affect appetite in healthy volunteers. Abstract Volumes of Experimental Biology: 1185, 1993
  14. Albu J, Dowling H, Allison D, Pi-Sunyer FX. Decreased HDL-cholesterol is independently associated with insulin resistance and not with hyperinsulinemia in obese glucose tolerant women. Diabetes, 42(suppl.1):234A, 1993
  15. Albu J, Dowling H, Allison D, Pi-Sunyer FX. Insulin resistance and body composition in obese healthy women. Obesity Research, 1(suppl.2): 81S, 1993
  16. Albu J, Dowling H, Allison D, Pi-Sunyer FX. HDL cholesterol and insulin resistance in obese glucose tolerant women. Obesity Research, 1(suppl.2): 95S, 1993.
  17. Segal KR, Chun A, Albu J, Pi-Sunyer FX. Effects of acute exercise on in vivo insulin action and glucose metabolism in lean and obese men. Clinical Research 42:174A, 1994.
  18. Albu J, Fried S, Pi-Sunyer FX. Measurements of insulin's antilipolytic effect in human adipocytes. Int. J Obesity, 18(2):93, 1994.
  19. Albu J, Curi M, Matthews D, Pi-Sunyer FX: Whole-body lipolysis and glucose disposal in obese, premenopausal, glucose tolerant women. . Diabetes Care, 18 (suppl): 18A, 1995.
  20. Albu J, Murphy L, Heymsfield S, Fraeger D, Johnson JA, Pi-Sunyer FX.. Body fat distribution in black and white premenopausal non-diabetic women. Am. J. Clin. Nutr., 61, (4): 800, 1995.
  21. Albu J, Murphy L, Johnson JA, Pi-Sunyer FX. Visceral fat distribution and carbohydrate metabolism in black and white, non-diabetic, obese women. J Investigative Medicine, 43: 234A, 1995
  22. Segal KR, Chun A, Albu J, Pi-Sunyer FX. Glucose uptake during exercise in lean and obese men. J Investigative Medicine, 43: 244A, 1995
  23. Albu J, Fried SK, Johnson JA, Shur M, Matthews DE, Pi-Sunyer FX. In vivo glycerol turnover rates correlate with the antilipolytic effect of insulin measured in vitro in isolated adipocytes of obese women. Obesity Research, 3(3): 352S, 1995
  24. Albu J, Shur M, Curi M, Murphy L, Heymsfield SB, Pi-Sunyer FX. Resting metabolic rate in obese, premenopausal African American women. The FASEB J, 10(3):A727, 1996
  25. Johnson JA, Albu J, Fried SK, Pi-Sunyer FX. Relationship between visceral fat and adipocyte insulin resistance in Caucasian and African-American women. The FASEB J. 10(3):A502, 1996
  26. Albu J, Shur M, Murphy L, Johnson JA, Matthews D, Pi-Sunyer FX.In vivo lipolysis in relation to adipose tissue distribution and in vitro insulin sensitivity in black and white obese premenopausal women. J of Investigative Med 44(3): 223A, 1996
  27. Albu, J, Matthwes D, Curi M, Shur M, Murphy L, Pi-Sunyer FX. Differential effects of visceral fat distribution and free fatty acid flux on insulin action and glucose tolerance in obese, nondiabetic women. Diabetes, 45(Suppl.2):98A, 1996
  28. rhIGF-I in Non-Insulin Dependent Diabetes Study (RINDS) Group: Recombinant insulin-like growth factor-I (rhIGF-I) treatment of non-insulin dependent diabetes mellitus (NIDDM): Effects of gender and prior hypoglycemic therapy. Diabetes, 45(Suppl.2): 17A, 1996
  29. rhIGF-I in Non-Insulin Dependent Diabetes Study (RINDS) Group. Evidence from a dose-ranging study that recombinant insulin-like growth factor-I (rhIGF-I) effectively and safely improves glycemic control in non-insulin dependent diabetes mellitus. Diabetes, 45(Suppl.2): 27A, 1996
  30. rhIGF-I in Non-Insulin Dependent Diabetes Study (RINDS) Group. Safety profiling of rhIGF-I therapy in patients with NIDDM: a dose ranging, placebo-controlled trial. Diabetes, 45(Suppl.2):71A, 1996.
  31. Albu, J, Matthews D.E. and Pi-Sunyer F.X. The effect of insulin on lipolysis, in vivo, in black and white obese women: relationship to visceral fat and insulin sensitivity of glucose uptake. The FASEB J, 11(3):A230, 1997.
  32. Kovera A, Gallagher D, Albu J, Wang J, Mathhews, DE, Heymsfield SB. Super obesity: a case study of body composition and changes with weight fluctuations. The FASEB J, 11(3):A594, 1997.
  33. Nathan JS, Heymsfield SB, Albu J, Pi-Sunyer FX, Allison DB. Descriptive results from Phase I of the BMI50 study: measurement challenges in the massively obese people. Presented at the Eastern Psychological Association. April 1997.
  34. Albu J, Murphy M, Meckler N, Matthews DE, Pi-Sunyer FX. The effect of insulin on lipolysis and on fat oxidation in black and white obese non-diabetic women: relationship with visceral fat. J Investigative Medicine. 45(3):250A, 1997.
  35. Albu J, Johnson JA, Fried SK, Pi-Sunyer FX. Insulin action in adipocytes from black and white women: relationship to visceral fat and insulin sensitivity index, Si. Diabetologia 40(Supplement 1):A258, 1997
  36. Albu J, Matthews DE, Pi-Sunyer FX. In vivo lipolysis in obese, nondiabetic, black and white women: relationship to visceral fat distribution. Diabetologia 40(Supplement 1):A258, 1997
  37. Johnson JA, Albu J, Fried SK, Pi-Sunyer FX. Lack of difference in lipolysis in omental and subcutaneous abdominal adipocytes from obese African-American women. Obesity Research, 5(Suppl. 1):20S, 1997
  38. Marcus MA, Murphy L, Pi-Sunyer FX, Albu J. Differential effect of visceral fat mass (VFM) and truncal subcutaneous fat (TrSQ) with respect to insulin sensitivity (Si) and serum triglyceride (TG) in obese, premenopausal, nondiabetic black and white women. Obesity Research, 5(Suppl.1):69S, 1997
  39. Albu J, Johnson JA, Fried SK, Pi-Sunyer FX. Low serum triglycerides are not related to rates of lipolysis in obese, insulin resistant African American women. Int J Obesity, S216, 1998
  40. Kovera AJ, Murphy L, Johnson JA, Albu J. Insulin resistance and subcutaneous fat distribution in African American women. Diabetes, 48(Suppl.1):A465, 1999
  41. Albu J, Johnson JA, Fried SK, Pi-Sunyer X. Variability in sensitivity to the antilipolytic effect of insulin in adipocytes from obese nondiabetic premenopausal women. Diabetes, 48(Suppl.1):A465, 1999
  42. Johnson JA, Albu J, Laferrere B, Fried SK, Pi-Sunyer FX. Relationship of serum leptin to subcutaneous adipocyte metabolism in African American and Caucasian obese premenopausal women. Presented at the Endocrine Society's 81 st Annual Meeting (ENDO'99), San Diego CA, June 12-15, 1999
  43. Engelson ES, Glesby M, Sheikhan J, Albu J, Wang J, Heymsfield SB, Kotler DP. Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection: interim analysis. Antiviral Therapy; 4(suppl.2):19, 1999.
  44. Kovera AJ, Tan Y, Gallagher D, Heymsfield SB, Albu J. Age and BMI are important determinants of fat distribution in women. Obesity Research. 7(suppl.1):107S, 1999
  45. Kelechi L, Taylor RR, Johnson JA, Albu J, Gillies P. Hydroxy-steroid dehydrogenase -1 (HSD1) expression is not dysregulated in obesity. Obesity Research. 7(suppl.1):72S, 1999
  46. Laferrere B, Fried SK, Osborne T, Uy N, Kovera AJ, Albu J, Pi-Sunyer FX. Synergistic effects of in vivo insulin and dexamethasone on serum leptin in humans. Obesity Research. 7(suppl.1):64S, 1999
  47. Reda TK, Kovera AJ, Fried S, Ashan A, Boozer C, Zhang K, Pi-Sunyer FX, Albu J. Differential effects of muscle lipoprotein lipase in lean and obese women. Presented at the Experimental Biology meeting, San Diego, CA, 2000
  48. Gallagher D, Albu J, Kovera AJ, Janumala F, Wong S, Heshka S. Smaller mass of high metabolically active organ-tissues in African American women. Obesity Research 8(1):17S, 2000
  49. Johnson JA, Ng KW, Albu J, Vasselli. High fat fed rats resistant to the feeding inhibitory effect of leptin are responsive to its lipolytic effect in adipose tissue. Obesity Research, 8(1):22S, 2000
  50. Kovera AJ, Bichis C, Reda T, Albu J. Body composition predictors of insulin resistance: studies using whole body multi-slice magnetic resonance imaging. Obesity Research, 8(1):47S, 2000
  51. Albu J, Kovera AJ, Heymsfield SB, Allison DB. Effect of fat distribution on lipid levels in women: studies using whole body MRI technique. Obesity Research. 8(1):121S, 2000
  52. Zahng K, Sun M, Kovera AJ, Werner P, Albu J, Pi-Sunyer FX, Boozer CN. A new way to examine sleeping metabolic rate. Obesity Research, 8(1):124S, 2000
  53. Johnson JA, Ynada Y, Flancbaum LJ, Albu J. Cytokine release in deep subcutaneous abdominal and visceral adipose tissue depots. Diabetes, 50(S2): A88, 2001
  54. Albu J, Johnson JA, Kovera A, Fried SK, Pi-Sunyer FX. Visceral adiposity and regional variation in lipolysis in obese nondiabetic women. Diabetes, 50(S2): A403, 2001
  55. Kovera A, Johnson JA, Pi-Sunyer FX , Albu J. The independent effect of abdominal adipocyte size on insulin sensitivity in premenopausal nondiabetic women. Diabetes, 50(S2): A516, 2001
  56. Johnson JA, Ng KW, Albu J, Vaselli JR. Leptin dose-dependently decreases the nonesterified fatty acid/glycerol ratio in adipocytes from rats fed high- and low-fat diets. Obesity Research, 9(S3): 64S, 2001
  57. Fernandez JR, Shriver MD, Rafla-Demetrious N, Para E, Albu J, Nicklas B, Ryan AS, Allison DB. Is African genetic admixture associated with BMI and resting metabolic rate in African American females? Obesity Research, 9(S3): 87S, 2001
  58. Lee VJ, Albu J, Kovera AJ, Johnson JA, Pi-Sunyer FX, Kim SM. Do Asian women have higher increasing rates of fasting insulin by BMI? Racial differences among Korean, Caucasian and African American women. Obesity Research, 9(S3): 98S, 2001
  59. Benjamin B, Cobb K, Thornton J, Allen L, Gallagher D, Albu J, Pi-Sunyer FX, Laferrere B. Newly defined abdominal region by DXA predicts abdominal fat by MRI. Obesity Research, 9(S3): 168S, 2001
  60. Thomas-Ghevargese A, Raghavan S, Marshall K, Oyeran S, Ramakrishnan R, Karmally, W, El-Sadr W, Albu J, Berglund L. Hyperinsulinemia in non-Caucasian HAART-treated HIV-positive patients. Presented at Endo 2002, P2-396, page 413
  61. Ionescu G, He Q, Engleson ES, Johnson JA, Albu J, Inada Y, Kotler DP. Acylation stimulating protein (ASP) and tumor necrosis factor (TNF) production in subcutaneous adipose tissue of HIV-infected patients with and without lipodystrophy. Presented at the XIV Int AIDS Conf, 2002,WePeA5794.
  62. Engleson ES, Agin D, Kenya S, He Q, Luty B, Werber-Zion G, Wang J, Heymsfield SB, Albu J, Kotler DP. The effects of a diet and exercise weight loss program in obese HIV-infected women. Presented at the XIV Int AIDS Conf, 2002, ThPeB7339.
  63. Albu JB, Engleson ES, Kenya S, Kovera A, Littschwager M, Wainwright M, Kotler DP. Insulin sensitivity and body composition in obese HIV+ women. Presented at the XIV Int AIDS Conf, 2002, ThPeB7356.
  64. Johnson J, Albu J, Engleson ES, Ionescu G, Sheikhan J, Kotler DP. Studies of subcutaneous adipose tissue (SAT) in HIV+ subjects with and without lipodystrophy. Presented at the XIV Int AIDS Conf, 2002, ThPeB7357.
  65. Kovera AJ, O'Rourke B, Matthews DE, Johnson JA, Wang J, Pi-Sunyer FX, Albu J. In vivo epinephrine stimulated lipolysis is related to visceral fat distribution in obese, nondiabetic women. Int J Obesity, 26(S1):S78, 2002
  66. Albu JB, Engelson E, Kenya S, Kovera A, Littschwager M, Wainwright M, Kotler D. Insulin sensitivity and body composition in obese HIV+ women. Int J Obesity 26(S1):S22, 2002
  67. Beasley TM, Fernandez JR, Albu J, Rafla-Demetrious N, Shriver MD, Nicklas B, Weinsier RL, Allison DB. Using reciprocal BMI for examinig African American admixture associations with obesity. Int J Obesity, 26(S1):S84, 2002
  68. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield S, Goodpaster M, Visser M, Harris T. Greater infiltration of adipose tissue in muscle of African-American compared to Caucasians. FASEB J, 17:772.2, 2003
  69. Kovera AJ, O'Rourke B, Matthews DE, Cho A, Johnson JA, Berk ES, Pi-Sunyer FX, & Albu J. Epinephrine-Stimulated In Vivo Lipolysis and Fat Oxidation in African American vs. Caucasian Women. J of Investigative Medicine, Vol 51, #2, 2003
  70. Kovera AJ, Allen L, Raja-Khan N, Wainwright M, Braunstein A, Gallagher D, Janumala F, Lee V, & Albu JB. Increased Insulin Resistance in African-American Compared to White Non-Hispanic Women: Lessons Learned from Whole-Body MRI Studies. Diabetes. Vol 52, Supp.1, June 2003, A329.
  71. Berk ES, Kovera AJ, Zhang K, Boozer CN, Wainright M, Pi-Sunyer F.X. & Albu JB. Systemic Fat Oxidation Inflexibility in African American vs. Caucasian Obese Women. Diabetes. Vol 52, Supp.1, June 2003, A24
  72. Heilbronn LK, Smith SR, McKolanis TM, Albu JB, Kelley D, and Ravussin E. Fat cell size, ectopic fat deposition and insulin resistance in subjects with or without Type 2 Diabetes. Diabetes. Vol 52, Supp.1, June 2003, A328
  73. Gallagher D, Kuznia P, Heshka S, Albu J, Heymsfield S, Goodpaster M, Visser M, Harris T. Greater infiltration of adipose tissue in muscle of African-American compared to Caucasians. FASEB J, 17:772.2, 2003
  74. Harris T, P Kuznia, S Heshka, J Albu, S Heymsfield, B Goodpaster, M Visser, & D Gallagher. Variations in muscle adipose tissue infiltration by weight/adipose tissue in pre-menopausal women. FASEB J 17:772.3, 2003.
  75. Kuznia P, T Harris, S Heshka, J Albu, S Heymsfield, B Goodpaster, M Visser, & D Gallagher. Thigh muscle adipose tissue infiltration versus total body. FASEB J 17:452.6, 2003
  76. Fernández J, Jones A, Shriver M, Albu J and Allison DB. Genetic Admixture is Associated with Visceral Adipose Tissue in Puerto Rican Females. Obesity Research, 11:A13, 2003
  77. Berk ES, Kovera AJ, Boozer CN, Pi-Sunyer FX, Johnson JA and Albu JB. Adiponectin Levels and Insulin Sensitivity during Low and High Fat Diets in Obese, Premenopausal Non-Diabetic Women. Obesity Research, 11:A34, 2003
  78. Johnson JA, Flancbaum LJ and Albu JB. Adiponectin release in deep subcutaneous abdominal and visceral adipose tissue depots. Obesity Research, 11:A35, 2003
  79. St-Onge MP, Jones A, Heymsfield SB, Albu JB. Body Weight and Fat-Free Mass Do Not Explain Resting Metabolic Rate Differences Between African-American and Caucasian Women. Obesity Research, 11:A63, 2003
  80. Harris T, Vissser M, Goodpaster B, Heshka S, Ding J, Kuznia P, Albu J, Heymsfield S, Gallagher D. Intermuscular adipose accumulation by age and gender compared to visceral and total adipose: evidence from whole body MRI. Obesity Research, 11: A26, 2003
  81. Heilbronn L, Rood J, Albu J, Kelley D, Ravussin E, Smith S. Plasma resistin concentrations in obesity and diabetes and its relationships with insulin action. Obesity Research, 11:A18, 2003
  82. Dubois S, Heilbronn L, Kelley D, Albu J, Smith S, Ravussin E. Expression of genes involved in adipocytes proliferation/differentiation in obesity and type 2 diabetes. Obesity Research, 11:A16, 2003
  83. Shen W, Punyanitya M, Wang Z, Gallagher D, St.-Onge MP, Albu J, Heymfield S, Heshka S. Total body adipose tissue and skeletal muscle volume: Prediction from a single abdominal cross-sectional image. Obesity Research. 12 (Supp.) A128, 2004.
  84. Berk E, Wainwright M, Kovera A, Zhang K, Boozer C, Pi-Sunyer FX, Albu J. Insulin resistance and metabolic inflexibility in African-American pre-menopausal women. Obesity Research. 12 (Supp.) A136, 2004.
  85. Gallagher D, Kelley D, Albu J, Boxt L, Pi-Sunyer FX, Heshka S. Altered adipose tissue distribution and less skeletal muscle mass in T2DM. Obesity Research. 12 (Supp.) A167, 2004.
  86. Thomas-Geevarghese A, Lu G, Raghavan S, Minolfo R, Ormsby B, Karmally W, El-Sadr W, Berglund L, Albu JB. Choice of protease inhibitor (PI) or non-nucleoside reverse transcriptase inhibitor (NNRTI)-based Highly Active Antiretroviral Therapy (HAART) in HIV-positive subjects affects postprandial adiponectin, free fatty acid, leptin and insulin response. To be presented at the Endocrine Society meeting, San Diego CA 2005
  87. Dubois S, Smith SR, Heilbronn LK, Bogacka I, Gimble JM, Kelley CA, Albu JB, Ravussin E and the Look AHEAD Adipose Research Group. Adiponectin Receptor 2 and AMPKa in Adipogenesis. To be presented at the ADA meeting San Diego CA June 2005
  88. Rassouli N, Johnson JA, Ionescu G, Minolfo R, Engelson ES, El-Sadr W , Kotler DP , Berglund L and Albu JB. Antiretroviral Therapy (ART) but not HIV Infection is Associated with Fat Distribution and Increased Subcutaneous Adipose Tissue (SAT) Secretion of IL-6 and TNF-a. To be presented at the Endocrine Society meeting, San Diego CA 2005
  89. Johnson JA, Berk ES,Garcia-Lorda P, Burkey, BF, Fried SK and Albu JB. Monocyte Chemoattractant Protein-1 (MCP-1) Secretion from Adipose Tissue Decreases with Weight Loss in Obese Pre-menopausal Women To be presented at the ADA meeting San Diego CA June 2005

STAFF PAGE
OBESITY RESEARCH CENTER HOME PAGE